4Wang C L，Abstracts the the 5th Congress of Asian Federation of Coloproctology，1995年
5Cheng C L，Methods Find Exp Clin Pharmacol，1994年，16卷，4期，271页
6Sherer D, Robinson JR and Kreuter J. Influencd of enzymes on the stability of polyhutylcyanoaerylate nanopartides.Int J Pharm, 1994,101(2):165
7Gallardo M, Cowarraze G, Denizot B. Study of the mechanisms of formation of nanoparticles and nanocapsales of polyisobutyl-2-cyanoacrylate.Int J Pharm,1994,190(1):55
8Li JK, Wang N, Wu XS. A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid)microspheres for protein and peptide drug delivery. J Pharm Sci, 1997,86(8):891
9Muller RH, Lherm C, Herbort J, et al. Alkylcyanoacrylate drug carties: I Physicochemical characterization of nanoparticles with different alkyl chain length. Int J. Pharm, 1992,84(1):1
10Cartherine L, Lherm C, Muller RH, et al. Alkylcyanoacrylate drug carries 2 cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm, 1992, 84(1):13
